[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.1410282 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1410282

New thread
>>>>1410281

>> No.1382115 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1382115

>>1382105
CERU my melanin male relative.

>> No.1339924 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1339924

>>1339861
Ok, here's the scoop on /ceru/ you dumb fucks. I'm going to divide this into 2 categories, CRLX101, and CRLX301.
>CRLX101
Has orphan drug status>http://www.ceruleanrx.com/platform-pipeline/crlx101.php
What that means is less than 200,000 new cases are documented or exist each year. It also means there's currently no effective treatment for the current disease, and it's highly deadly.
The FDA generally fast tracks these, as mentioned here, under Renal Cell Carcinoma
>The U.S. FDA has granted CRLX101 Fast Track designation in combination with Avastin for the treatment of metastatic renal cell carcinoma following progression through two or three prior lines of therapy.
Basically it means they may just skip phase 3 altogether, or cut it short and say their data is just so effective, it's hard to ignore and deny these DYING cancer patients a chance to live.
>CRLX301
The chief medical officer at ceru is Adrian Senderowicz
>http://www.ceruleanrx.com/about/management-team.php#Senderowicz
Senderowicz used to work for Sanofi-Aventis.
Sanofi-Aventis was FDA approved for a drug called docetaxel back in 1999 for small metastic lung cancer.
Docetaxel, as it turns out, is the main ingredient in ceru's CRLX301. Their 2nd drug.
It's already approved.... He used to work for the company which it was approved under.... It's going to work.
Altogether the markets for CRLX101 ALONE come to more than 4.5billion annually, with CRLX301 targeting all hard tumors in general there's no telling how much people may pay.
Here's the greatest catch...
They have 0 SUCCESSFUL competitors.

>> No.1306450 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1306450

>>1306440
NIGGER BRO NO SKIN PIC
WHERE'S THE SKIN PIC ASSHOLE?

>> No.1270524 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1270524

New thread
>>1270521

>> No.1227690 [View]
File: 17 KB, 350x268, AAAAYERRRYBODY.jpg [View same] [iqdb] [saucenao] [google]
1227690

Given the orphan drug status of CLRX101 and the ground breaking work of CLRX301.
>What would /biz/ value CERU at if both drugs are FDA approved?
>CLRX101 is approved?
>CLRX301 only?

Navigation
View posts[+24][+48][+96]